Even Packaging Can Multitask - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Even Packaging Can Multitask
Interphex attendees found packaging machines and containers with increased functionality. This article contains online bonus material.


Pharmaceutical Technology
Volume 6, Issue 34, pp. 34-36

Modular monoblocs


The servo-driven Filamatic Monobloc fill–finish packaging system handles round or square containers ranging in size from 10 to 1000 mL. (PHOTO IS COURTESY OF FILAMATIC.)
A high degree of flexibility is built into a modular monobloc for filling and finishing rigid containers. Capable of handling round or square containers ranging in size from 10 to 1000 mL, the servo-driven system can be equipped with either a peristaltic or piston pump. An optional high-efficiency particulate air (HEPA) filtration system provides positive-pressure airflow in the filling area (Monobloc fill–finish packaging system, Filamatic, Baltimore, MD).

Another highly flexible monobloc fills and closes microtubes or bottles and can change from one to the other in 30 min. Capable of filling volumes as great as 250 mL, the system's maximum speed is 45 containers/min. The microtube setup consists of a vibratory bowl to orient tubes, a linear filling line, and screw capping. Bottles rely on rotary turntables at the infeed and outfeed and crimp capping. Hygienic design, HEPA filtration, and compatibility with barrier systems or isolators make the system suitable for sterile products (P1520-BT monobloc, M&O Perry Industries, Corona, CA).

Yet another monobloc fits the needs of laboratoriess, pilot plants, and clinical-trial packaging. It can fill from 1 to 100 mL at speeds as high as 45 containers/min. Capable of filling, stoppering, and crimping aluminum caps, the system enables tool-free changeover to be completed in less than 10 min. The single-operator machine is designed for cleanroom environments (Model FSAS—2205 Tabletop, Chase-Logeman, Greensboro, NC).


The MHI vial-filling and -closing machine from Bosch is targeted toward low-volume applications and suited for clinical-trial packaging. (PHOTO IS COURTESY OF BOSCH.)
Clinical trials and low-volume applications also are addressed by a highly flexible vial filler equipped with two robots. The first robot transfers a vial from the infeed and sets it on a weigh cell for filling. After the accuracy of the fill is verified, the other robot moves the vial to the stoppering station. Interchangeable filling options include piston, peristaltic, and rolling-diaphragm pumps. Personal-computer-based control ensures precise fills and minimal product waste. The unit handles as many as 60 glass or plastic containers per minute. Servo control automates changeover, which involves a minimum of change parts. A small footprint and isolator-ready construction enhance functionality (MHI vial-filling and -closing machine, Bosch Packaging Technology, Waiblingen, Germany).

A syringe-assembly machine inserts the plunger rod into 1-, 2- or 5-mL syringe bodies and applies labels. The compact machine also incorporates a printer to print a lot number and expiration date on the label and a vision system to verify the information and label placement. Three models handle speeds of 100, 200, and 400 syringes/min. An inclined exit raises the syringes to the level of the thermoformer. Options include assembly of back stops and safety devices (Hasta plunger-rod inserting machine, MG America, Fairfield, NJ). The plunger-rod inserting machine can be integrated with a complete line, including a syringe denester, thermoformer, cartoner, and case packer.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
18%
To all process for new products only
13%
To select process for new products only
22%
To select processes for both new and legacy products
22%
Do not use QbD
24%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Inadequate Access to Medicines Puts EU at Risk
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here